Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPA-15406 (Difamilast) Ointment in Pediatric Atopic Dermatitis
NCT05650320Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Feb 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of difamilast in atopic dermatitis (AD), sponsored by Otsuka Holdings. Started Feb 2023; status: completed.
02
Drugs
difamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05650320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05650320.